"Rocky Mountain Cancer Centers (RMCC) is Colorado's largest and most comprehensive provider of cancer care with over 50 physicians, in nearly 20 community-based locations across the state. Our history is rich in forward thinking and best practice development. We were formed in 1992 when a group of independent medical oncology practices joined together to become a network of community-based clinic sites. This practice model has stood the test of time and continues to have proven clinical and economic benefit for patients, employers and payers today."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
73
SWOG Cancer Research Network
32
Alliance for Clinical Trials in Oncology
24
ECOG-ACRIN Cancer Research Group
14
Pfizer
8
NRG Oncology
6
Eli Lilly and Company
5
GOG Foundation
3
Eastern Cooperative Oncology Group
2
Gynecologic Oncology Group
2
BeiGene
1
Clinical Trials at Rocky Mountain Cancer Centers-Sky Ridge
During the past decade, Rocky Mountain Cancer Centers-Sky Ridge conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 70 clinical trials were completed, i.e. on
average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 46 clinical trials were completed. i.e. 148.4%
of trials that started reached the finish line.
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 32 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "Pfizer"
with 14 trials sponsored. Other sponsors include 32 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Cancer Centers-Sky Ridge"
#1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator and "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at Rocky Mountain Cancer Centers-Sky Ridge
According to Clinical.Site data, the most researched conditions in "Rocky Mountain Cancer Centers-Sky Ridge" are
"Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Rocky Mountain Cancer Centers-Sky Ridge" in a lesser frequency.
Clinical Trials Intervention Types at Rocky Mountain Cancer Centers-Sky Ridge
Most popular intervention types in "Rocky Mountain Cancer Centers-Sky Ridge" are "Drug" (146 trials), "Other" (110 trials), "Biological" (80 trials), "Procedure" (44 trials) and "Radiation" (14 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (45 trials), "Questionnaire Administration" (25 trials), "Biospecimen Collection" (24 trials) and "Computed Tomography" (24 trials). Other intervention names were less common.
Clinical Trials Genders at Rocky Mountain Cancer Centers-Sky Ridge
The vast majority of trials in "Rocky Mountain Cancer Centers-Sky Ridge" are
149 trials for "All" genders, 35 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Rocky Mountain Cancer Centers-Sky Ridge
Currently, there are NaN active trials in "Rocky Mountain Cancer Centers-Sky Ridge".
undefined are not yet recruiting,
46 are recruiting,
86 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in Rocky Mountain Cancer Centers-Sky Ridge,
5 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Rocky Mountain Cancer Centers-Sky Ridge, 5 "Phase 1"
clinical trials were conducted, 87 "Phase 2" clinical
trials and 93 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 5 trials that are defined as “Not Applicable".